Media Coverage
Source: Daily Journal
Media Coverage
12.04.14
A Pillsbury team represented Receptos Inc., a San Diego-based biopharmaceutical company, in a $414 million stock offering completed Nov. 24. According to The Daily Journal, the company offered 4,140,000 shares of common stock at $100 per share, and the offering included 540,000 shares purchased by the underwriters.
Receptos works to develop drugs used to treat metabolic and immune diseases and says it will use proceeds of the offering to fund work on a drug to treat multiple sclerosis, ulcerative colitis and Crohn’s disease, as well as for general corporate purposes.
Corporate & Securities-Tech partners Mike Hird and Patty DeGaetano led the Pillsbury team with assistance from Intellectual Property partner Richard Blaylock and Tax partner C. Brian Wainwright.